C WorldWide Group’s Vaxcyte PCVX Stock Holding History

C WorldWide Group’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Hold	195,000	–	–	0.27%	51
2026 Q1	$11.3M	Hold	195,000	–	–	0.24%	48
2025 Q4	$9M	Hold	195,000	–	–	0.16%	63
2025 Q3	$7.02M	Hold	195,000	–	–	0.11%	67
2025 Q2	$6.34M	Buy	195,000 +100,000	+105%	+$3.28M	0.09%	68
2025 Q1	$3.59M	Buy	+95,000	New	+$7.6M	0.04%	72

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

C WorldWide Group's PCVX Position: Q2 2026 in Review

C WorldWide Group held its Vaxcyte (PCVX) position steady in Q2 2026 at 195,000 shares worth $11.3M. The position accounts for 0.27% of the portfolio, ranked #51.

C WorldWide Group first reported a position in PCVX in Q1 2025 and has held it in 6 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

C WorldWide Group held 195,000 shares of Vaxcyte worth $11.3M as of Q2 2026.
C WorldWide Group left its Vaxcyte share count unchanged in Q2 2026.
Vaxcyte made up 0.27% of C WorldWide Group's portfolio in Q2 2026, its #51 holding.
C WorldWide Group first reported a position in Vaxcyte in Q1 2025 and has held it in 6 quarters since.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.